Research Grants

Pharmaceutical studies, dollar amounts not available

Devous, M., Observational Study of Long-Term (18-Month) Cognitive Outcomes in Health Volunteers, Patients with Mild Cognitive Impairment and Patients With Alzheimer’s Disease Who Have Previously Had PET Imaging With Study Agent Injection; Lotan, Y., An Investigation of the Study Test for Early Detection of Bladder Cancer.

Olsen, N., A Randomized, Double-Blind, Placebo-Controlled, Single Dose-Escalation and Multiple-Dose Extension Trial of Study Drug Administered Intravenously or Subcutaneously in Subjects With Systemic Lupus Erythematosus; Pierce, A., A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Study Drug When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma.

Stoll, M., A Phase 4, Six-Week, Randomized, Double-Blind, Multicenter, Active-Controlled Trial to Evaluate the Effects of Celecoxib (Celebrex) or Naproxen on Blood Pressure in Pediatric Subjects With Juvenile Idiopathic Arthritis; Torres, F., A Multicenter, Open-Label, Multiple-Dose, Dose-Finding Study Exploring the Safety and Tolerability of Study Drug in PAH Patients.

Torres, F., An Open-Label Extension of Study Drug in Pulmonary Arterial Hypertension Patients; Torres, F., A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Oral Study Drug Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension.

Trimmer, C., A Prospective, Randomized, Concurrently Controlled, Post-Approval Study of the Flair Endovascular Stent Graft (Renova); Verma, V., A Randomized, Open-Label, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Study Drug vs. Imatinib Gastrointestinal Stromal Tumors.

Vusirikala, M., A Phase II Study of Study Drug in Combination With Bendamustine and Rituximab in Subjects With Relapsed or Refractory Follicular Lymphoma; Weiner, M. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmaco-kinetic Effects of Study Drug in the Treatment of Patients With Prodromal Alzheimer’s Disease.

Share: